Skip to main content

Matthew Brusch promoted to CEO of NIRI; Ilisa Bernstein named interim CEO of APhA

NIRI CEO Matthew Brusch CEO departuresAPhA announces leadership changeThe American Pharmacists Association announced June 2 that Ilisa Bernstein had been named interim CEO following the departure of Scott Knoer. Knoer was chief pharmacy officer at the Cleveland Clinic before joining $36M-revenue APhA in 2020. The association did not give a reason for his departure.Bernstein has been APhA's SVP of pharmacy practice and government affairs for the past 2? years. Previously, she held leadership positions at the Food and Drug Administration. She has a doctor of pharmacy degree from the University of Michigan and a law degree from American University."We have full confidence in… Read More